GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Santhera Pharmaceuticals Holding AG (OTCPK:SPHDF) » Definitions » Pretax Margin %

Santhera Pharmaceuticals Holding AG (Santhera Pharmaceuticals Holding AG) Pretax Margin % : -594.54% (As of Jun. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Santhera Pharmaceuticals Holding AG Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Santhera Pharmaceuticals Holding AG's Pre-Tax Income for the six months ended in Jun. 2023 was $-26.01 Mil. Santhera Pharmaceuticals Holding AG's Revenue for the six months ended in Jun. 2023 was $4.38 Mil. Therefore, Santhera Pharmaceuticals Holding AG's pretax margin for the quarter that ended in Jun. 2023 was -594.54%.

The historical rank and industry rank for Santhera Pharmaceuticals Holding AG's Pretax Margin % or its related term are showing as below:

SPHDF' s Pretax Margin % Range Over the Past 10 Years
Min: -1257.34   Med: -198.95   Max: 3430.53
Current: -1257.34


SPHDF's Pretax Margin % is ranked worse than
75.56% of 1027 companies
in the Biotechnology industry
Industry Median: -176.72 vs SPHDF: -1257.34

Santhera Pharmaceuticals Holding AG Pretax Margin % Historical Data

The historical data trend for Santhera Pharmaceuticals Holding AG's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santhera Pharmaceuticals Holding AG Pretax Margin % Chart

Santhera Pharmaceuticals Holding AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -170.15 -24.40 -449.48 3,430.14 -944.91

Santhera Pharmaceuticals Holding AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -442.28 572.55 -466.11 -3,391.47 -594.54

Competitive Comparison of Santhera Pharmaceuticals Holding AG's Pretax Margin %

For the Biotechnology subindustry, Santhera Pharmaceuticals Holding AG's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santhera Pharmaceuticals Holding AG's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Santhera Pharmaceuticals Holding AG's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Santhera Pharmaceuticals Holding AG's Pretax Margin % falls into.



Santhera Pharmaceuticals Holding AG Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Santhera Pharmaceuticals Holding AG's Pretax Margin for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-75.801/8.022
=-944.91 %

Santhera Pharmaceuticals Holding AG's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-26.011/4.375
=-594.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Santhera Pharmaceuticals Holding AG  (OTCPK:SPHDF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Santhera Pharmaceuticals Holding AG Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Santhera Pharmaceuticals Holding AG's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Santhera Pharmaceuticals Holding AG (Santhera Pharmaceuticals Holding AG) Business Description

Traded in Other Exchanges
Address
Hohenrainstrasse 24, Pratteln, CHE, 4133
Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives most of its revenue from the European Union.